Stock Events

Stock Events

Search...

Paion

€0.01

17

+€0+0% Wednesday 10:11

Statistics

Day High

0.01

Day Low

0.01

52W High

6.91

52W Low

0.01

Volume

46

Avg. Volume

5,068

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

22AugExpected

Q4 2019

Q1 2020

Q2 2020

Q3 2020

Q3 2020

Q1 2021

Q2 2021

-0.11

-0.07

-0.04

0

Expected EPS

0

Actual EPS

-0.1045

Financials

-1.74%Profit Margin

Unprofitable

2017

2018

2019

2020

2021

2022

33.25MRevenue

-579,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0NF3.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with Paion in the development of drugs across various therapeutic areas, including anesthesia where Paion has a focus.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing medications that can overlap with Paion's portfolio, including anesthesia and critical care.

Merck & Co., Inc. is involved in the discovery, development, and marketing of drugs in areas that can compete with Paion's interests, particularly in anesthesia and pain management.

AbbVie competes with Paion in the pharmaceutical sector, focusing on areas including anesthesia and pain management, where Paion also operates.

Novartis AG is a global healthcare company that has a broad portfolio, including drugs in the anesthesia area, making it a competitor to Paion.

Bristol-Myers Squibb

Bristol-Myers Squibb Company is involved in the discovery and development of drugs in several therapeutic areas that could compete with Paion's focus areas.

AstraZeneca operates in various therapeutic segments, including areas that overlap with Paion's drug development efforts, making it a competitor.

Sanofi is a global pharmaceutical company with a wide range of products that could compete with Paion, especially in the development of anesthesia-related treatments.

GlaxoSmithKline plc is involved in the creation and marketing of pharmaceutical products, including those in areas that compete with Paion's focus.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. is a global company that manufactures generic and specialty medicines, including those in the field of anesthesia, competing with Paion.

About

Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for out-patient and hospital-based sedation, anesthesia, and critical care services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in final stage of clinical development for use in procedural sedation, as well as in other indications, such as general anesthesia and intensive care unit sedation. It has partnerships and license agreements with Cosmo Pharmaceuticals, Yichang Humanwell, R-Pharm, TR-Pharm, Hana Pharm, Pharmascience, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.

Show more...

CEO

Employees

50

Country

DE

ISIN

DE000A3E5EG5

Listings

0 Comments

Share your thoughts

FAQ

What is Paion stock price today?▼

The current price of 0NF3.LSE is €0.01 EUR — it has increased by +0% in the past 24 hours. Watch Paion stock price performance more closely on the chart.

What is Paion stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Paion stocks are traded under the ticker 0NF3.LSE.

What is Paion revenue for the last year?▼

Paion revenue for the last year amounts to 33.25M EUR.

What is Paion net income for the last year?▼

0NF3.LSE net income for the last year is -579,000 EUR.

How many employees does Paion have?▼

As of February 11, 2026, the company has 50 employees.

In which sector is Paion located?▼

Paion operates in the Energy sector.

When did Paion complete a stock split?▼

Paion has not had any recent stock splits.